Marksans Pharma Ltd Quarterly Results

Gross Sales

641.92

590.62

560.01

586.13

531.24

Excise Duty

0

0

0

0

0

Net Sales

641.92

590.62

560.01

586.13

531.24

Other Operating Income

0

0

0

0

0

Other Income

11.06

14.95

16.53

4.8

19

Total Income

652.98

605.57

576.54

590.93

550.23

Total Expenditure

506.24

462.18

450.37

453.11

417.29

PBIDT

146.74

143.39

126.17

137.82

132.95

Interest

2.63

2.92

4.84

3.16

1.63

PBDT

144.11

140.46

121.33

134.66

131.32

Depreciation

19.51

20.44

21.06

22

17.55

Minority Interest Before NP

0

0

0

0

0

Tax

36.29

30.01

30.74

28.07

29.78

Deferred Tax

-9.45

0.94

-8.11

1.63

0.13

Reported Profit After Tax

97.76

89.07

77.64

82.97

83.85

Minority Interest After NP

1.04

0.32

-0.65

-0.27

0.33

Net Profit after Minority Interest

96.72

88.75

78.29

83.24

83.52

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

96.72

88.75

78.29

83.24

83.52

EPS (Unit Curr.)

2.13

1.96

1.73

1.84

1.84

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

45.32

45.32

45.32

45.32

45.32

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

22.85

24.27

22.52

23.51

25.02

PBDTM(%)

22.44

23.78

21.66

22.97

24.71

PATM(%)

15.22

15.08

13.86

14.15

15.78